Canopy Growth (TSX:WEED) Stock: Why I Finally Bought Some

Why now is the time to buy some Canopy Growth Corp (TSX:WEED)(NYSE:CGC) shares.

| More on:

The cannabis industry is relatively new with a lot of unknowns and uncertainties. Therefore, investing in weed stocks is speculative.

However, if you want to participate in the high-growth industry, and it isn’t a good opportunity to buy a global leader and the dominant player in the country (i.e., Canopy Growth (TSX:WEED)(NYSE:CGC)) after the stock has corrected by more than 50% from its high, I don’t know what is.

WEED Chart

WEED data by YCharts.

Analysts have an average price target of $56.60 per share on WEED stock, which represents a discount of more than 40% or upside potential of 77%!

Recent highlights

For fiscal first-quarter 2020, Canopy Growth reported net revenue of $90.5 million, which was up 249% against the comparable quarter a year ago. The company increased dried cannabis sales in the Canadian recreational market by 94% over Q4 2019 and increased international medical cannabis revenue by 209% versus Q1 2019.

Canopy Growth harvested 40,960 kilograms, an increase of 183% over the prior quarter. This greatly exceeded its prior estimate of 34,000 kilograms. This is significant because the first-quarter harvest was the first full-scale harvest since it began retrofitting its large-scale greenhouse facilities in 2018, and with the majority of the work completed at the facilities, Canopy Growth will be shifting its focus on optimization to increase yield and lower cost.

In the quarter, Canopy Growth filed 56 patent applications, bringing the company’s patent portfolio to an industry-leading 111 patents and 270 patent applications.

Why the stock correction is a buying opportunity

What might have driven the stock lower is the gross margin compression; the margin fell from 43% a year ago to 15%.

Canopy Growth explained that the lower margin was predominantly due to operating costs related to facilities that haven’t begun production yet and a shift in product mix.

WEED’s gross margin should rebound meaningfully in subsequent quarters. In a recent press release, the company’s CEO, Mark Zekulin had a positive tone stating, “Fiscal 2020 is going to be another exciting time for the cannabis industry as we close in on the launch of new product formats. Our recent harvests are proof that our focus on operational excellence is working, and we look forward to showing both our Canadian and U.S. customers what we’ve been working on behind the scenes to prepare for the next wave of products coming later this year.”

Investor takeaway

At under $32 per share as of writing, WEED stock trades at about 34 times sales and two times book, which is a massive discount of 74% and 61%, respectively, from its five-year multiples. So, now is an opportunistic entry point for investors with a big appetite for risk and volatility and have an investment horizon of at least three years.

I fully expect WEED stock to be a bumpy ride. And that’s why I only bought a third of a position with room to add should it fall some more. If not, I’m happy trading this for short-term gains should the stock move materially higher.

Fool contributor Kay Ng owns shares of Canopy Growth.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »